Other recently suggested mechanisms of AD action involving lipid accumulation and neurotrophin signaling [13, 55] can also be discounted on the basis of their requirement of micromolar drug concentrations, 1–2 orders of magnitude beyond the therapeutic range used in our study. Here, BDNF is linked to Alzheimer disease.